Pat Morin, PhD, is senior director of scientific review and grants administration at the AACR. Following his studies in biophysics at the University of Quebec, Canada, where he received his bachelor’s and master’s degrees, Morin obtained his PhD from Boston University in 1995. He completed postdoctoral training at the Johns Hopkins Oncology Center in the laboratory of Bert Vogelstein, MD, where he studied the molecular genetics of colorectal cancer. In 1998, he joined the NIH to head a laboratory focused on ovarian cancer research. In particular, his group was one of the first to perform gene expression profiling in ovarian cancer and, in 2000, he first identified claudin proteins as being abnormally expressed in cancer. These findings led to research investigating the possible use of claudins in targeted therapies and in the detection of various cancers. He also held an assistant professor position at the Johns Hopkins School of Medicine, Department of Pathology, from 1998 until 2012, when he accepted his current position at the AACR. Morin has published over 80 peer-reviewed articles in the field of cancer. In addition, he has been on the editorial board of several journals, including Cancer Research, and has served as a reviewer of more than 250 manuscripts submitted to various scientific journals. Morin also holds several patents. He has given many lectures as an invited speaker and has chaired several scientific symposia.
We observe May as National Cancer Research Month to celebrate the tremendous advances that have been made in our understanding of cancer and ways to fight it. It’s also a …Read More